Clinical Trial: A Study to Test Whether BI 456906 Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
Study Status: Completed
Recruit Status: RECRUITING
Condition: Obesity
Study Type: INTERVENTIONAL
Official Title: A Phase 3, Randomised, Double-blind, Parallel-group, 76-week, Efficacy and Safety Study of BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity Withou
Brief Summary:
This study is open to adults who are at least 18 years old and havea body mass index (BMI) of 30 kg/m² or more, ora BMI of 27 kg/m² or more and at least one health problem related to their weight.People with type 2 diabetes cannot take part in this study.Only people who have previously not managed to lose weight by changing their diet can participate.The purpose of this study is to find out whether a medicine called survodutide (BI 456906) helps people living with overweight or obesity to lose…
Read more